Mirum Pharmaceuticals, Inc. (MIRM)
86.30
-1.54
(-1.75%)
USD |
NASDAQ |
Mar 06, 16:00
87.39
+1.09
(+1.26%)
After-Hours: 20:00
Mirum Pharmaceuticals SG&A Expense (TTM) : 257.03M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 701.17M |
| BridgeBio Pharma, Inc. | 531.22M |
| Pfizer Inc. | 13.79B |
| XOMA Royalty Corp. | 32.68M |
| Recursion Pharmaceuticals, Inc. | 176.59M |